Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP990861.RAgPQm7vWtp0tzCnabPlDRpgPxFR9UPWW0eLQDkD9OpUc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP990861.RAgPQm7vWtp0tzCnabPlDRpgPxFR9UPWW0eLQDkD9OpUc130_assertion type Assertion NP990861.RAgPQm7vWtp0tzCnabPlDRpgPxFR9UPWW0eLQDkD9OpUc130_head.
- NP990861.RAgPQm7vWtp0tzCnabPlDRpgPxFR9UPWW0eLQDkD9OpUc130_assertion description "[The results showed the frequency of the Asp299Gly genotype was increased in patients with chronic disease (OR 25.3, 95% CI 5.2-115.6, P�<�0.001) and patients with acute disease (OR 8.03, 95% CI 1.7-37.7, P�=�0.006) compared to LST negative subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP990861.RAgPQm7vWtp0tzCnabPlDRpgPxFR9UPWW0eLQDkD9OpUc130_provenance.
- NP990861.RAgPQm7vWtp0tzCnabPlDRpgPxFR9UPWW0eLQDkD9OpUc130_assertion evidence source_evidence_literature NP990861.RAgPQm7vWtp0tzCnabPlDRpgPxFR9UPWW0eLQDkD9OpUc130_provenance.
- NP990861.RAgPQm7vWtp0tzCnabPlDRpgPxFR9UPWW0eLQDkD9OpUc130_assertion SIO_000772 21056683 NP990861.RAgPQm7vWtp0tzCnabPlDRpgPxFR9UPWW0eLQDkD9OpUc130_provenance.
- NP990861.RAgPQm7vWtp0tzCnabPlDRpgPxFR9UPWW0eLQDkD9OpUc130_assertion wasDerivedFrom befree-20150227 NP990861.RAgPQm7vWtp0tzCnabPlDRpgPxFR9UPWW0eLQDkD9OpUc130_provenance.
- NP990861.RAgPQm7vWtp0tzCnabPlDRpgPxFR9UPWW0eLQDkD9OpUc130_assertion wasGeneratedBy ECO_0000203 NP990861.RAgPQm7vWtp0tzCnabPlDRpgPxFR9UPWW0eLQDkD9OpUc130_provenance.